https://www.prnewswire.com/news-releases/obi-pharma-announces-poster-presentations-at-2020-asco-virtual-annual-meeting-for-adagloxad-simolenin-obi-999-and-obi-3424-301062263.html
OBI Pharma Announces Poster Presentations at 2020 ASCO Virtual Annual Meeting for Adagloxad...
/PRNewswire/ -- OBI Pharma, Inc. (TPEx: 4174), a leader in Glycosphingolipid Immuno-Oncology therapeutics targeting the Globo Series antigens (Globo H and...